HRTX

Heron Therapeautics (HRTX)

Heron Therapeautics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:HRTX

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/06/01	00:08	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:HRTX	Heron Therapeautics Inc
2024/05/29	21:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HRTX	Heron Therapeautics Inc
2024/05/29	21:05	PR Newswire (US)	Heron Therapeutics Announces Prior Approval Supplement Submission to the FDA for ZYNRELEF® Vial Access Needle ("VAN")	NASDAQ:HRTX	Heron Therapeautics Inc
2024/05/07	21:05	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:HRTX	Heron Therapeautics Inc
2024/05/07	21:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HRTX	Heron Therapeautics Inc
2024/05/07	21:00	PR Newswire (US)	Heron Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Corporate Updates	NASDAQ:HRTX	Heron Therapeautics Inc
2024/04/24	21:00	PR Newswire (US)	Heron Therapeutics to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024	NASDAQ:HRTX	Heron Therapeautics Inc
2024/04/12	05:05	PR Newswire (US)	Heron Therapeutics to Host Investor Day on May 15, 2024 in New York City	NASDAQ:HRTX	Heron Therapeautics Inc
2024/03/29	05:05	PR Newswire (US)	Heron Therapeutics Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference	NASDAQ:HRTX	Heron Therapeautics Inc
2024/03/14	05:25	AllPennyStocks.com	Biotech Finds Mid-Week Success Following Q4 Earnings Release	NASDAQ:HRTX	Heron Therapeautics Inc
2024/03/13	05:05	PR Newswire (US)	Heron Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate Updates	NASDAQ:HRTX	Heron Therapeautics Inc
2024/03/12	20:22	IH Market News	Global Markets Await U.S. Inflation Report: Mixed Movements in Pre-Market Trading	NASDAQ:HRTX	Heron Therapeautics Inc
2024/02/28	22:00	PR Newswire (US)	Heron Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results On Tuesday, March 12, 2024	NASDAQ:HRTX	Heron Therapeautics Inc
2024/02/15	06:37	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:HRTX	Heron Therapeautics Inc
2024/02/15	06:21	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:HRTX	Heron Therapeautics Inc
2024/02/14	22:46	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:HRTX	Heron Therapeautics Inc
2024/01/24	23:25	AllPennyStocks.com	Premarket Heats Up For Biotech Before Opening Bell	NASDAQ:HRTX	Heron Therapeautics Inc
2024/01/24	22:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HRTX	Heron Therapeautics Inc
2024/01/24	10:00	PR Newswire (US)	Heron Therapeutics Announces FDA Approval of ZYNRELEF® Indication Expansion to Include Additional Orthopedic and Soft Tissue Procedures	NASDAQ:HRTX	Heron Therapeautics Inc
2024/01/20	11:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HRTX	Heron Therapeautics Inc
2024/01/20	11:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HRTX	Heron Therapeautics Inc
2024/01/20	11:04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HRTX	Heron Therapeautics Inc
2024/01/20	11:04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HRTX	Heron Therapeautics Inc
2024/01/20	11:04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HRTX	Heron Therapeautics Inc
2024/01/20	11:04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HRTX	Heron Therapeautics Inc
2024/01/20	11:03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HRTX	Heron Therapeautics Inc
2024/01/20	11:03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HRTX	Heron Therapeautics Inc
2024/01/20	11:02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HRTX	Heron Therapeautics Inc
2024/01/20	11:02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HRTX	Heron Therapeautics Inc
2024/01/20	11:01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HRTX	Heron Therapeautics Inc